Exenatide tQT Study Showed No Prolongation of QT Interval - Drugs.com MedNews

Links shared publicly online about this topic.

  • 162
    total visits

Exenatide tQT Study Showed No Prolongation of QT Interval - Drugs.com MedNews

drugs.com

Results to be Included in BYDUREON(TM) New Drug Application Resubmission in the Third Quarter of 2011 SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., July 07, 2011

View full resource at drugs.com

Tags: Diabetes Type 2 Medication, Diabetes Medication, Drug, Byetta

  • Share

Most Recently Shared on July 8, 2011 at 1:10 pm By:

Drugs_Devices Drugs and Devices OW

Exenatide tQT Study Showed No Prolongation of QT Interval: Results to be Included in BYDUREON(TM) New Drug... http://bit.ly/pFJnM4 #drug

11 months ago...

Eli Lilly and Company - Exenatide tQT Study Showed No Prolongation of QT Interval

newsroom.lilly.com — “Eli Lilly and Company - Exenatide tQT Study Showed No Prolongation of QT IntervalView full resource at newsroom.lilly.com

  • View Related
  • Share

Most Recently Shared on July 8, 2011 at 6:19 pm By:

Glycosmedia Jim Health News

Exenatide tQT Study Showed No Prolongation of QT Interval (lilly) http://bit.ly/p2xaDV

11 months ago...

Advertisement